DG

Daniel W. Gil

AB AbbVie: 83 patents #12 of 1,308Top 1%
TR The Arizona Board Of Regents: 4 patents #22 of 428Top 6%
HH Hepco Holdings: 3 patents #2 of 9Top 25%
Overall (All Time): #17,990 of 4,157,543Top 1%
90
Patents All Time

Issued Patents All Time

Showing 25 most recent of 90 patents

Patent #TitleCo-InventorsDate
11638836 Sterilization device utilizing low intensity UV-C radiation and ozone Patricia Carol Gil, Asher Gil 2023-05-02
11331306 Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases Mohammed I. Dibas, John E. Donello 2022-05-17
11077053 Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, visual starbursts, visual halos and night myopia Mohammed I. Dibas, Wayne Chen, Miguel Alcantara 2021-08-03
11046756 Heavy chain only antibodies to ANG-2 Yanbin Liang 2021-06-29
11028163 Heavy chain only antibodies to PDGF Yanbin Liang 2021-06-08
10596282 Sterilization device utilizing low intensity UV-C radiation and ozone Patricia Carol Gil, Asher Gil 2020-03-24
10555933 Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases Mohammed I. Dibas, John E. Donello 2020-02-11
10335505 Sterilization device for incision and wound sites utilizing low intensity UV-C radiation and ozone Patricia Carol Gil, Asher Gil 2019-07-02
10308711 Heavy chain only antibodies to PDGF Yanbin Liang 2019-06-04
10266589 Heavy chain only antibodies to ANG-2 Yanbin Liang 2019-04-23
10251865 Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists John E. Donello, Veena Viswanath, Lauren M. Luhrs 2019-04-09
10201535 Pharmaceutical compositions comprising 7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions Mohammed I. Dibas, Edward C. Hsia, John E. Donello 2019-02-12
9889088 Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect Mohammed I. Dibas, John E. Donello 2018-02-13
9849113 Methods of treating α adrenergic mediated conditions John E. Donello, Wenkui K. Fang, Phong X. Nguyen, Ken Chow, Todd M. Heidelbaugh +3 more 2017-12-26
9637467 Treatment of inflammatory bowel disease Yariv Donde, Jeremiah H. Nguyen, Karen M. Kedzie, John E. Donello, Wha-Bin Im 2017-05-02
9623006 Methods of treating α adrenergic mediated conditions John E. Donello, Wenkui K. Fang, Phong X. Nguyen, Ken Chow, Todd M. Heidelbaugh +3 more 2017-04-18
9561234 Methods for treating diseases of the retina Jyotirmoy Kusari, Sheila X. Zhou, Mingting Tian, Edwin U. Padillo, Sandhya Rao +1 more 2017-02-07
9555021 Pharmaceutical compositions comprising (3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl)methanol 2017-01-31
9545394 Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists John E. Donello, Veena Viswanath, Lauren M. Luhrs 2017-01-17
9522150 Alpha adrenergic receptor modulators Ken Chow, Liming Wang, Wenkui K. Fang, Evelyn G. Corpuz, Santosh C. Sinha +2 more 2016-12-20
9308201 Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions Mohammed I. Dibas, Edward C. Hsia, John E. Donello 2016-04-12
9289420 Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists John E. Donello, Veena Viswanath, Lauren M. Luhrs 2016-03-22
9283217 Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions Mohammed I. Dibas, Edward C. Hsia, John E. Donello 2016-03-15
9193690 Pharmaceutical compositions comprising (3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl)methanol 2015-11-24
9156810 Treatment of inflammatory bowel disease Yariv Donde, Jeremiah H. Nguyen, Karen M. Kedzie, John E. Donello, Wha-Bin Im 2015-10-13